Why a wrong-route medication error can cause serious harm

A medicine's route is part of the prescription, not a minor label detail. An oral liquid, an injectable product, an inhaled medicine, and an eye drop are designed for different sites and methods of use. Sending a product to the wrong body site can make treatment ineffective or expose the patient to harm. The result depends on the drug, amount, patient, and route, so a route error needs prompt professional assessment.

What counts as a wrong-route error

A wrong-route error occurs when a medicine is administered or supplied for use by a route other than the route ordered or intended. Examples include an oral product given through an enteral tube contrary to its formulation instructions, an injectable preparation mistaken for an oral product, or an infusion connected to the wrong line. A route mismatch can arise during prescribing, transcription, dispensing, preparation, handoff, or administration.

Why the consequences can be serious

Routes affect where a medicine goes and how the body absorbs it. The wrong route may result in too little medicine reaching the intended site, too much or too rapid exposure, local tissue injury, toxicity, infection, or delayed care. FDA has also documented serious harm from misconnections between medical devices: a connector intended for one system may fit a different system, allowing medication or another substance to enter the wrong body area. These events show why route and connection checks are safety-critical.

Practical prevention checks

At each relevant handoff, compare the medication order with the selected product and its label. Check the drug, strength, dosage form, route, and directions together. Look for products with similar names or packaging, especially when different routes are stocked nearby. Barcode scanning, separated storage, standardized concentrations, clear labeling, and independent checks for high-risk processes can reduce error opportunities when required by the pharmacy's procedures.

FDA cautions that color coding alone is not a reliable safeguard against device misconnections. The better defense combines connectors designed for specific systems, staff training, distinct storage and workflow, labels, and deliberate tracing of a line from its origin to its destination. A technician should follow the facility's approved process and route any uncertainty to the pharmacist or responsible clinician.

The technician's scope

A pharmacy technician should identify and communicate a mismatch, not independently decide that a different route is clinically acceptable. Do not alter a prescription, convert a dosage form, or advise a patient to use a medicine by a new route without pharmacist direction and appropriate authorization. If an error is suspected after dispensing or administration, escalate immediately so the pharmacist and care team can assess the patient and determine the next steps.

Exam traps

• Treating route as interchangeable when the drug name and strength look correct.
• Changing dosage form or route to make a prescription easier to fill.
• Assuming a label color guarantees the correct tubing connection.
• Failing to escalate because the medicine has not yet caused a visible reaction.
• Confusing a technician's duty to flag a discrepancy with authority to make a clinical decision.

Key takeaway

Confirm the route at each handoff. When the order, dosage form, product, or connection does not agree, pause and escalate. Route errors can be serious even before symptoms appear.

Route must match the order, dosage form, and device

A route error occurs when medication is taken or administered by a route different from the authorized one. A familiar drug name and strength do not make oral, topical, inhaled, ophthalmic, otic, rectal, and injectable products interchangeable. Check the route across the prescription, product, label, packaging, and any device or connector. A mismatch should stop the process before the product reaches the patient. Technicians should not convert a dosage form or change the route to make a prescription easier to fill.

Some serious errors arise when a product intended for one route can physically connect to equipment for another. Color cues alone are not enough; follow device design, labels, training, and local connection controls. Keep products in original packaging when required and avoid removing route-identifying labels. If an order is ambiguous or the product selected has a different route, isolate the item and ask the pharmacist. If a route error may have reached a patient, escalate immediately even when no symptoms are visible.

Practical checks, exceptions, and exam application

Route checks should happen at multiple handoffs: order entry, product selection, labeling, final verification, and patient or care-team handoff. Read the actual dosage form and route rather than relying on shelf position or familiar packaging. In institutions, trace tubing and connectors from source to destination according to policy. Separate products with similar names but different routes and use auxiliary labels or storage controls when approved. A barcode can assist but cannot replace attention to the order and the physical product.

If a route discrepancy is found before dispensing, hold the item and document or route the clarification according to procedure. If it may have reached the patient, notify the pharmacist immediately and preserve the packaging and label. The pharmacist coordinates with the prescriber or care team, evaluates urgency, and determines disclosure and follow-up. Do not wait for symptoms; route errors can cause harm even when the patient initially feels well.

A technician may notice that an oral liquid was entered as an injection, a topical product was selected for an eye, or a device connection is incompatible. The correct response is to stop and escalate, not to decide which route seems clinically plausible. The fact that the active ingredient matches does not make the routes interchangeable.